Delivery Order SPE2DB20D3303-SPE2DB25FA3KP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 100-gram quantities, with a ceiling value of $1,704.94. This contract, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, utilizes firm fixed-price pricing and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Pimecrolimus 1% Cream in 60-gram quantities, with a contract ceiling value of $1,021.20. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,557.56 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This non-competitive, firm fixed-price delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in a 30-gram unit, with a contract value of $1,125.26. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in a 30-gram quantity, valued at $20,510.86. This delivery order, issued on September 11, 2025, represents a firm fixed-price contract with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units, with a ceiling value of $10,804.84 and an ultimate completion date of May 2, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply action supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities, with a ceiling value of $4,473.45. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pimecrolimus...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 100-gram quantities, with a ceiling value of $2,181.45. The contract was competitively awarded without set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,024.44 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 30-gram units, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and utilizes a child delivery order structure under AmerisourceBergen's larger contract vehicle with DLA. The product will be performed from the vendor's facility in Conshohocken, Pennsylvania, supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a $2,458.75 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 100-gram units, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3KPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream (30gm) on September 8, 2025, with a ceiling value of $1,002.05. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and carries no set-aside designation. The contract was competitively awarded and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the agency. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor with a demonstrated track record of fulfilling federal medical procurement requirements across multiple therapeutic domains through competitive contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/8/25 |